PREDICT Heliox in Childhood Croup

Research into practise: Heliox in childhood croup survey

A Mater Children’s Hospital team completed a Cochrane review which showed that Heliox may have similar benefits to nebulised adrenaline for moderate to severe childhood croup. Heliox would require additional equipment and may not be cost effective. The PREDICT network of emergency departments in Australia and New Zealand reviewed management of croup in 2008 and showed no use of Heliox. The goal of this study was to update the 2008 evidence through a survey of 15 PREDICT site representatives. This data will help in implementation of the Cochrane review into practice.

Study design

Multi centre cross sectional survey

Chief investigator

Irene Moraa (Mater), David Herd (Mater, PREDICT)





Site locations

  • Starship Children’s Hospital, New Zealand
  • KidzFirst Middlemore Hospital, New Zealand
  • Royal Children’s Hospital, Melbourne, Australia
  • Monash Children’s Hospital, Victoria, Australia
  • Townsville Hospital, Townsville, Queensland, Australia
  • Royal Children’s Hospital, Brisbane, Australia
  • Mater Children’s Hospital, Brisbane, Australia
  • Gold Coast Hospital, Southport, Queensland, Australia
  • Sydney Children’s Hospital, Randwick, Sydney, Australia
  • Children’s Hospital at Westmead, Sydney, Australia
  • John Hunter Hospital, Newcastle, Australia
  • Women’s and Children’s Hospital, Adelaide, Australia
  • Sunshine Hospital, Melbourne, Australia
  • The Children’s Hospital at Westmead, Sydney, Australia
  • Canberra Hospital, Australian Capital Territory, Australia


15 site representatives